Kura Oncology Corp has a consensus price target of $567.61 based on the ratings of 38 analysts. The high is $1350 issued by HSBC on May 10, 2024<. The low is $100 issued by Deutsche Bank on August 5, 2024. The 3 most-recent analyst ratings were released by New Street Research, Goldman Sachs, and Deutsche Bank on August 6, 2024, August 5, 2024, and August 5, 2024, respectively. With an average price target of $118.33 between New Street Research, Goldman Sachs, and Deutsche Bank, there's an implied 0.21% upside for Kura Oncology Corp from these most-recent analyst ratings.
1calculated from analyst ratings
Buy Now | Get Alert | |||||||
---|---|---|---|---|---|---|---|---|
03/06/2025 | Buy Now | — | UBS | David Dai26% | $27 → $14 | Maintains | Buy | Get Alert |
02/27/2025 | Buy Now | — | HC Wainwright & Co. | Joseph Pantginis45% | $40 → $40 | Reiterates | Buy → Buy | Get Alert |
02/06/2025 | Buy Now | — | JMP Securities | Reni Benjamin46% | $28 → $28 | Reiterates | Market Outperform → Market Outperform | Get Alert |
02/06/2025 | Buy Now | — | Wedbush | Robert Driscoll44% | $34 → $36 | Maintains | Outperform | Get Alert |
02/06/2025 | Buy Now | — | HC Wainwright & Co. | Joseph Pantginis45% | $37 → $40 | Maintains | Buy | Get Alert |
01/08/2025 | Buy Now | — | Scotiabank | George Farmer42% | $18 → $10 | Maintains | Sector Perform | Get Alert |
12/09/2024 | Buy Now | — | Cantor Fitzgerald | Li Watsek40% | — | Reiterates | Overweight → Overweight | Get Alert |
11/26/2024 | Buy Now | — | Cantor Fitzgerald | Li Watsek40% | — | Reiterates | → Overweight | Get Alert |
11/22/2024 | Buy Now | — | B of A Securities | Jason Zemansky74% | $36 → $29 | Maintains | Buy | Get Alert |
11/21/2024 | Buy Now | — | TD Cowen | Phil Nadeau64% | — | Reiterates | → Buy | Get Alert |
11/21/2024 | Buy Now | — | Jefferies | Roger Song33% | $32 → $28 | Maintains | Buy | Get Alert |
11/21/2024 | Buy Now | — | Cantor Fitzgerald | Li Watsek40% | — | Reiterates | → Overweight | Get Alert |
11/21/2024 | Buy Now | — | HC Wainwright & Co. | Joseph Pantginis45% | $32 → $37 | Maintains | Buy | Get Alert |
11/19/2024 | Buy Now | — | JMP Securities | Reni Benjamin46% | $32 → $32 | Reiterates | Market Outperform → Market Outperform | Get Alert |
11/18/2024 | Buy Now | — | HC Wainwright & Co. | Joseph Pantginis45% | $32 → $32 | Reiterates | Buy → Buy | Get Alert |
11/13/2024 | Buy Now | — | HC Wainwright & Co. | Joseph Pantginis45% | $32 → $32 | Reiterates | Buy → Buy | Get Alert |
11/06/2024 | Buy Now | — | Cantor Fitzgerald | Li Watsek40% | — | Reiterates | → Overweight | Get Alert |
11/06/2024 | Buy Now | — | HC Wainwright & Co. | Joseph Pantginis45% | $32 → $32 | Reiterates | Buy → Buy | Get Alert |
10/24/2024 | Buy Now | — | UBS | David Dai26% | → $27 | Initiates | → Buy | Get Alert |
10/24/2024 | Buy Now | — | HC Wainwright & Co. | Joseph Pantginis45% | $32 → $32 | Reiterates | Buy → Buy | Get Alert |
10/14/2024 | Buy Now | — | Stifel | Bradley Canino41% | $26 → $19 | Downgrade | Buy → Hold | Get Alert |
09/09/2024 | Buy Now | — | Cantor Fitzgerald | Li Watsek40% | — | Reiterates | → Overweight | Get Alert |
08/12/2024 | Buy Now | — | JMP Securities | Reni Benjamin46% | $32 → $32 | Reiterates | Market Outperform → Market Outperform | Get Alert |
08/12/2024 | Buy Now | — | HC Wainwright & Co. | Joseph Pantginis45% | $32 → $32 | Reiterates | Buy → Buy | Get Alert |
08/09/2024 | Buy Now | — | Cantor Fitzgerald | Li Watsek40% | — | Reiterates | → Overweight | Get Alert |
08/09/2024 | Buy Now | — | Wedbush | Robert Driscoll44% | $37 → $37 | Reiterates | Outperform → Outperform | Get Alert |
08/09/2024 | Buy Now | — | Stifel | Bradley Canino41% | $28 → $26 | Maintains | Buy | Get Alert |
06/24/2024 | Buy Now | — | HC Wainwright & Co. | Joseph Pantginis45% | $32 → $32 | Reiterates | Buy → Buy | Get Alert |
06/18/2024 | Buy Now | — | JMP Securities | Reni Benjamin46% | $32 → $32 | Reiterates | Market Outperform → Market Outperform | Get Alert |
05/16/2024 | Buy Now | — | JMP Securities | Reni Benjamin46% | $32 → $32 | Reiterates | Market Outperform → Market Outperform | Get Alert |
05/14/2024 | Buy Now | — | HC Wainwright & Co. | Joseph Pantginis45% | $32 → $32 | Reiterates | Buy → Buy | Get Alert |
05/06/2024 | Buy Now | — | JMP Securities | Reni Benjamin46% | $32 → $32 | Reiterates | Market Outperform → Market Outperform | Get Alert |
05/03/2024 | Buy Now | — | Wedbush | Robert Driscoll44% | $37 → $37 | Reiterates | Outperform → Outperform | Get Alert |
05/03/2024 | Buy Now | — | HC Wainwright & Co. | Joseph Pantginis45% | $32 → $32 | Reiterates | Buy → Buy | Get Alert |
04/22/2024 | Buy Now | — | HC Wainwright & Co. | Joseph Pantginis45% | $32 → $32 | Reiterates | Buy → Buy | Get Alert |
03/06/2024 | Buy Now | — | HC Wainwright & Co. | Joseph Pantginis45% | $32 → $32 | Reiterates | Buy → Buy | Get Alert |
02/28/2024 | Buy Now | — | Stifel | Bradley Canino41% | $27 → $28 | Maintains | Buy | Get Alert |
02/28/2024 | Buy Now | — | HC Wainwright & Co. | Joseph Pantginis45% | $32 → $32 | Reiterates | Buy → Buy | Get Alert |
02/28/2024 | Buy Now | — | Wedbush | Robert Driscoll44% | $37 → $37 | Reiterates | Outperform → Outperform | Get Alert |
01/31/2024 | Buy Now | — | Mizuho | Mara Goldstein57% | $26 → $32 | Maintains | Buy | Get Alert |
01/31/2024 | Buy Now | — | JMP Securities | Reni Benjamin46% | $22 → $32 | Maintains | Market Outperform | Get Alert |
12/22/2023 | Buy Now | — | Mizuho | Mara Goldstein57% | → $26 | Initiates | → Buy | Get Alert |
12/08/2023 | Buy Now | — | HC Wainwright & Co. | Joseph Pantginis45% | → $32 | Reiterates | Buy → Buy | Get Alert |
11/03/2023 | Buy Now | — | Wedbush | Robert Driscoll44% | $40 → $37 | Maintains | Outperform | Get Alert |
10/18/2023 | Buy Now | — | Wedbush | Robert Driscoll44% | → $40 | Reiterates | Outperform → Outperform | Get Alert |
09/07/2023 | Buy Now | — | Cantor Fitzgerald | Li Watsek40% | → $30 | Reiterates | Overweight → Overweight | Get Alert |
08/11/2023 | Buy Now | — | B of A Securities | Jason Zemansky74% | → $31 | Initiates | → Buy | Get Alert |
08/04/2023 | Buy Now | — | Stifel | Bradley Canino41% | $25 → $24 | Maintains | Buy | Get Alert |
07/27/2023 | Buy Now | — | Scotiabank | George Farmer42% | → $10.5 | Initiates | → Sector Perform | Get Alert |
07/21/2023 | Buy Now | — | Cantor Fitzgerald | Li Watsek40% | → $30 | Reiterates | Overweight → Overweight | Get Alert |
06/13/2023 | Buy Now | — | Cantor Fitzgerald | Li Watsek40% | → $30 | Reiterates | Overweight → Overweight | Get Alert |
06/13/2023 | Buy Now | — | JMP Securities | Reni Benjamin46% | → $22 | Reiterates | Market Outperform → Market Outperform | Get Alert |
06/12/2023 | Buy Now | — | HC Wainwright & Co. | Joseph Pantginis45% | → $32 | Reiterates | Buy → Buy | Get Alert |
06/12/2023 | Buy Now | — | Stifel | Bradley Canino41% | $24 → $25 | Maintains | Buy | Get Alert |
05/17/2023 | Buy Now | — | BTIG | Justin Zelin41% | → $31 | Initiates | → Buy | Get Alert |
05/11/2023 | Buy Now | — | Credit Suisse | Tiago Fauth43% | → $26 | Reiterates | Outperform → Outperform | Get Alert |
05/11/2023 | Buy Now | — | HC Wainwright & Co. | Joseph Pantginis45% | → $32 | Reiterates | Buy → Buy | Get Alert |
04/17/2023 | Buy Now | — | JMP Securities | Reni Benjamin46% | → $22 | Reiterates | → Market Outperform | Get Alert |
02/24/2023 | Buy Now | — | HC Wainwright & Co. | Joseph Pantginis45% | → $32 | Reiterates | → Buy | Get Alert |
02/10/2023 | Buy Now | — | HC Wainwright & Co. | Joseph Pantginis45% | → $32 | Reiterates | → Buy | Get Alert |
01/31/2023 | Buy Now | — | Stifel | Bradley Canino41% | → $25 | Initiates | → Buy | Get Alert |
07/13/2022 | Buy Now | — | Credit Suisse | Tiago Fauth43% | $27 → $29 | Maintains | Outperform | Get Alert |
07/12/2022 | Buy Now | — | Cantor Fitzgerald | Li Watsek40% | → $30 | Initiates | → Overweight | Get Alert |
The latest price target for Kura Oncology (NASDAQ:KURA) was reported by UBS on March 6, 2025. The analyst firm set a price target for $14.00 expecting KURA to rise to within 12 months (a possible 117.73% upside). 34 analyst firms have reported ratings in the last year.
The latest analyst rating for Kura Oncology (NASDAQ:KURA) was provided by UBS, and Kura Oncology maintained their buy rating.
There is no last upgrade for Kura Oncology
The last downgrade for Kura Oncology Inc happened on October 14, 2024 when Stifel changed their price target from $26 to $19 for Kura Oncology Inc.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Kura Oncology, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Kura Oncology was filed on March 6, 2025 so you should expect the next rating to be made available sometime around March 6, 2026.
While ratings are subjective and will change, the latest Kura Oncology (KURA) rating was a maintained with a price target of $27.00 to $14.00. The current price Kura Oncology (KURA) is trading at is $6.43, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.